Atlas Trials

Study of Efficacy and Safety of CTL019 in Adult ALL Patients

Clinical trial NCT02167360 · WITHDRAWN

Trial details

NCT number
NCT02167360
Sponsor
Abramson Cancer Center at Penn Medicine
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
B-cell Acute Lymphoblastic LeukemiaRelapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic Leukemia
Start date
2016-06-01
Primary completion
2017-01-11
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.